English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Stem cell memory T (T SCM ) and central memory T (T CM ) cells can rapidly differentiate into effector memory (T EM ) and terminal effector (T EF ) T cells, and have the most potential for immunotherapy. In this study, we found that the frequency of T SCM  and T CM  cells in the CD8+ population dramatically decreased together with increases in T EM  and T EF  cells, particularly in younger patients with acute myeloid leukemia (AML) (< 60 years). These alterations persisted in patients who achieved complete remission after chemotherapy. The decrease in T SCM  and T CM  together with the increase in differentiated T EM  and T EF  subsets in CD8+ T cells may explain the reduced T cell response and subdued anti-leukemia capacity in AML patients.

Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia